Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for Bio-Techne (TECH) over the last 17 years, with Q4 2025 value amounting to -$5.9 million.

  • Bio-Techne's Cash from Investing Activities fell 1766.69% to -$5.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$13.8 million, marking a year-over-year increase of 7347.64%. This contributed to the annual value of -$35.2 million for FY2025, which is 8267.1% up from last year.
  • Bio-Techne's Cash from Investing Activities amounted to -$5.9 million in Q4 2025, which was down 1766.69% from $605000.0 recorded in Q3 2025.
  • In the past 5 years, Bio-Techne's Cash from Investing Activities ranged from a high of $605000.0 in Q3 2025 and a low of -$241.1 million during Q1 2023
  • In the last 5 years, Bio-Techne's Cash from Investing Activities had a median value of -$12.7 million in 2024 and averaged -$41.6 million.
  • In the last 5 years, Bio-Techne's Cash from Investing Activities plummeted by 2800155.04% in 2022 and then skyrocketed by 10460.94% in 2025.
  • Over the past 5 years, Bio-Techne's Cash from Investing Activities (Quarter) stood at -$35.2 million in 2021, then surged by 99.69% to -$109000.0 in 2022, then plummeted by 21616.51% to -$23.7 million in 2023, then surged by 78.74% to -$5.0 million in 2024, then dropped by 17.67% to -$5.9 million in 2025.
  • Its Cash from Investing Activities was -$5.9 million in Q4 2025, compared to $605000.0 in Q3 2025 and $406000.0 in Q2 2025.